Heyford Park, Oxford, UK: 2BScientific, a leading life science products distributor, has signed an agreement that will see the company become the exclusive UK and Ireland distribution partner of San Diego-based IMGENEX Corporation, which develops and commercializes novel reagents including antibodies, gene and protein expression systems, and functional genomics arrays.

James Bernard, Managing Director of 2BScientific, said: “The agreement with IMGENEX means we are now offering an incredible range of products and solutions to the UK and Ireland biotech R&D community. We are very proud to partner with such an innovative company – we believe IMGENEX has an excellent product portfolio and we look forward to providing them our customers, particularly those focusing in cancer, apoptosis, molecular signaling pathways, cellular aging, and metabolic and infectious diseases.”

Jonathan Rosenberg, Corporate Development at IMGENEX, commented: “As we grow and develop the IMGENEX business in our strategic areas, it’s important we work with world-class distributors who are eager and able to align uncompromised efforts with focus and expansion beyond our specialty areas such as Innate Immunity and Immunology, Inflammation and Immune Signaling Pathways, Apoptosis and Cancer Research. We welcome the opportunity to work with 2BScientifc to enable placing our products in the hands of life science researchers, helping them to bring success to their work. With an excellent reputation as a distributor and a strong team, 2BScientifc is in a perfect position to help us expand the market for our product lines in the UK and Ireland.”

Customers visiting the 2BScientific website at www.2BScientific.com will be able to purchase IMGENEX’s products, including the new Apoptosis Detection range that features Annexin V Apoptosis Detection Kits; Caspase Activity Detection Kits; Mitochondrial Permeability Detection Kits and pSIVA — the first reversible apoptosis probe for detecting phosphatidylserine exposure on plasma membranes.”